EN
HI
Summary
As of 31 Oct, 2026, Windlas Biotech stock price is ₹876.1. During the trading session, the stock has moved between an intraday low of ₹865.50 and an intraday high of ₹921.70. Over the last 52 weeks, Windlas Biotech has traded between ₹697.40 and ₹1181.90.
The stock has recorded a trading volume of 55,277 shares,. Its Average Traded Price (ATP) is ₹886.60, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 20 @ ₹876.10.
Windlas Biotech has an upper circuit limit of ₹1051.30 and a lower circuit limit of ₹700.90. The total value traded stands at ₹4.90 CR, and the delivery percentage for the day is 43.69%.
The stock is currently traded with a market lot size of 1. Windlas Biotech also offers a dividend yield of 0.72%.
Windlas Biotech Share Price Chart
Windlas Biotech Share Key Metrics
Volume
55277.00
Market Cap
1807.94 CR
LTQ@LTP
20@876.10
ATP
886.6
Var Margin
19.82 %
Circuit Range
700.9-1051.3
Delivery %
43.69 %
Value
4.90 CR
ASM/GSM
No
Market Lot
1
Windlas Biotech Fundamentals
P/E Ratio
27.24
P/B Ratio
3.52
Div. Yield
0.72
Sector P/E
39.15
Sector P/B
3.25
Sec. Div. Yield
0.52
Windlas Biotech Resistance and Support
Pivot 915.6
Resistance
First Resistance
944.2
Second Resistance
965
Third Resistance
993.6
Support
First Support
894.8
Second Support
866.2
Third Support
845.4
Windlas Biotech Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Oct 30 2026 | 920.8 | 876.1 | -5.12% | 921.7 | 865.5 |
| Thu Oct 29 2026 | 899.7 | 923.4 | 3.90% | 936.4 | 887 |
| Wed Oct 28 2026 | 883.29 | 888.7 | 1.29% | 899 | 873 |
Windlas Biotech Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-10 | Quarterly Results |
| 2026-05-21 | Audited Results & Final Dividend |
| 2026-04-17 | Buy Back of Shares |
| 2026-02-05 | Quarterly Results |
| 2025-11-06 | Quarterly Results |
| 2025-08-12 | Quarterly Results |
| 2025-05-22 | Audited Results & Final Dividend |
| 2025-02-11 | Quarterly Results |
| 2024-11-12 | Quarterly Results |
| 2024-08-13 | Quarterly Results |
Windlas Biotech News
Windlas Biotech Ltd - 543329 - Board Meeting Intimation for Approval Of Unaudited Standalone Financial Results For The Quarter And Half Year Ended September 30, 2026
Windlas Biotech board of directors will meet on 5 Nov 2026. The primary agenda is to approve the financial results.
Oct 30 2026 12:26:54
Windlas Biotech Management
| Name | Position |
|---|---|
| Ananta Narayan Panda | Company Secretary & Compliance Officer |
| Ashok Kumar Windlass | Whole Time Director |
Windlas Biotech Similar Stocks
Sai Parenteral's Ltd.
521.95
16.25 (3.21%)
Panacea Biotec Ltd.
313.25
-12.65 (3.88%)
Indoco Remedies Ltd.
208.30
-1.20 (0.57%)
Syncom Formulations (India) Ltd.
19.24
-1.17 (5.73%)
Hester Biosciences Ltd.
2289.30
-18.30 (0.79%)
Venus Remedies Ltd.
1796.10
0.00 (0.00%)
NGL Fine-Chem Ltd.
2526.00
-86.80 (3.32%)
Suraksha Diagnostic Ltd.
316.35
-3.20 (1.00%)
Krsnaa Diagnostics Ltd.
503.75
5.80 (1.16%)
Jagsonpal Pharmaceuticals Ltd.
216.09
-5.85 (2.64%)
Windlas Biotech FAQs
The Buying Price of Windlas Biotech share is 876.1 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Windlas Biotech stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Windlas Biotech, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Windlas Biotech shares is 27.24. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Windlas Biotech shares is 3.52. Useful to assess the stock's value relative to its book value.
To assess Windlas Biotech’s valuation compare Sector P/E, P/B which are 39.15 & 3.25 with sector averages, along with growth rates and financial metrics.
The Market Cap of Windlas Biotech is 1807.94 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Windlas Biotech share price is 1181.90 & 697.40. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Windlas Biotech belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in WINDLAS
